Hijery ny anatiny

Oncologie (pédiatrie)

Immunothérapie

Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. (manokatra rohy)

Kantarjian H, Stein A, Gökbuget N, Fielding AK, Schuh AC, Ribera JM, Wei A, Dombret H, Foà R, Bassan R, Arslan Ö, Sanz MA, Bergeron J, Demirkan F, Lech-Maranda E, Rambaldi A, Thomas X, Horst HA, Brüggemann M, Klapper W, Wood BL, Fleishman A, Nagorsen D, Holland C, Zimmerman Z, Topp MS

Loharanon-kevitra‎: N Engl J Med 2017;376(9):836-47.

Rakitra‎: PubMed 28249141

DOI‎: 10.1056/NEJMoa1609783

https://www.ncbi.nlm.nih.gov/pubmed/28249141 (manokatra rohy)

Chimeric antigen receptor T cells for sustained remissions in leukemia. (manokatra rohy)

Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, Chew A, Gonzalez VE, Zheng Z, Lacey SF, Mahnke YD, Melenhorst JJ, Rheingold SR, Shen A, Teachey DT, Levine BL, June CH, Porter DL, Grupp SA

Loharanon-kevitra‎: N Engl J Med 2014;371(16):1507-17.

Rakitra‎: PubMed 25317870

DOI‎: 10.1056/NEJMoa1407222

https://www.ncbi.nlm.nih.gov/pubmed/25317870 (manokatra rohy)

Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. (manokatra rohy)

Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA, Grupp SA

Loharanon-kevitra‎: N Engl J Med 2018;378(5):439-48.

Rakitra‎: PubMed 29385370

DOI‎: 10.1056/NEJMoa1709866

https://www.ncbi.nlm.nih.gov/pubmed/29385370 (manokatra rohy)

Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia. (manokatra rohy)

O'Hear C, Inaba H, Pounds S, Shi L, Dahl G, Bowman WP, Taub JW, Pui CH, Ribeiro RC, Coustan-Smith E, Campana D, Rubnitz JE

Loharanon-kevitra‎: Cancer 2013;119(22):4036-43.

Rakitra‎: PubMed 24006085

DOI‎: 10.1002/cncr.28334

https://www.ncbi.nlm.nih.gov/pubmed/24006085 (manokatra rohy)

Gemtuzumab ozogamicin reduces relapse risk in FLT3/ITD acute myeloid leukemia: a report from the Children's Oncology Group. (manokatra rohy)

Tarlock K, Alonzo TA, Gerbing RB, Raimondi SC, Hirsch BA, Sung L, Pollard JA, Aplenc R, Loken MR, Gamis AS, Meshinchi S

Loharanon-kevitra‎: Clin Cancer Res 2016;22(8):1951-7.

Rakitra‎: PubMed 26644412

DOI‎: 10.1158/1078-0432.CCR-15-1349

https://www.ncbi.nlm.nih.gov/pubmed/26644412 (manokatra rohy)

ONCOLOGIE (PÉDIATRIE)
Immunothérapie
Malagasy
Immunothérapie
https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Tompon’andraikitra eo An-toerana

Afaka miantso an’io sampan’asa io foana ny dokotera mitsabo Vavolombelon’i Jehovah, na andro na alina.

Adiresy sy Telefaonina

Fanazavana Momba ny Fitsaboana

Ireto avy no hita ato: Teknika fitsaboana tsy ampiasana ra rehefa very ra be na tsy ampy ra ilay marary, ny zavatra inoan’ny Vavolombelon’i Jehovah sy ny fitsaboana arahiny mifanaraka amin’izany, ary ny fanampiana omen’ny Vavolombelon’i Jehovah ny mpitsabo amin’ny alalan’ireo anisan’ny Komity Mifandray Amin’ny Hopitaly.

Zavatra Azo Alaina

Video

Izay azon’ny dokotera eritreretina sy isafidianana rehefa mitsabo Vavolombelon’i Jehovah.

Hijery Video